JPT Peptides Technologies (BioNTech) Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
61
- Latest Deal Type
-
Debt Repay.
- Financing Rounds
-
3
JPT Peptides Technologies (BioNTech) General Information
Description
Provider of peptide-based services, catalog products, and kits along with research and development services for projects in immunology, proteomics, and drug discovery. The company's service line includes sero marker discovery, protein-protein interaction profiling, antibody epitope mapping, histone code analysis, and bioinformatics facilities. It also manufactures peptide products, such as custom peptides, stabs isotope-labeled peptides, and immunogenic peptides for clients in the pharmaceutical and biotechnology industries and researchers in universities, governmental, and non-profit organizations.
Contact Information
Website
www.jpt.com(Operating Subsidiary)
Corporate Office
- Volmerstrasse 5
- 12489 Berlin
- Germany
Corporate Office
- Volmerstrasse 5
- 12489 Berlin
- Germany
JPT Peptides Technologies (BioNTech) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
JPT Peptides Technologies (BioNTech) Comparisons
Industry
Financing
Details
JPT Peptides Technologies (BioNTech) Competitors (13)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GenScript | Formerly VC-backed | Piscataway, NJ | ||||
| Numaferm | Venture Capital-Backed | Dusseldorf, Germany | ||||
| ProSci (Poway) | Private Equity-Backed | Poway, CA | ||||
| ARVYS Proteins | Corporation | Trumbull, CT | ||||
| Eurofins Genomics Americas | Corporation | Louisville, KY |
JPT Peptides Technologies (BioNTech) Patents
JPT Peptides Technologies (BioNTech) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3426667-A2 | Detection of neurodegenerative diseases | Inactive | 07-Mar-2016 | ||
| US-20190094246-A1 | Detection of neurodegenerative diseases | Inactive | 07-Mar-2016 | ||
| US-11046745-B2 | Peptide mimotopes of the cd3 t-cell co-receptor epsilon chain and uses thereof | Active | 14-Jul-2015 | ||
| US-20190070248-A1 | Peptide mimotopes of the cd3 t-cell co-receptor epsilon chain and uses thereof | Active | 14-Jul-2015 | ||
| EP-3322715-A1 | Peptide mimotopes of the cd3 t-cell co-receptor epsilon chain and uses thereof | Active | 14-Jul-2015 | A61K47/646 |
JPT Peptides Technologies (BioNTech) Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Holger Wenschuh | Managing Director | |
| Sean Marett | Managing Director | |
| Alexandra Fritschi | Director of Finance & Administration | |
| Sierk Poetting Ph.D | Managing Director |
JPT Peptides Technologies (BioNTech) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
JPT Peptides Technologies (BioNTech) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
JPT Peptides Technologies (BioNTech) FAQs
-
When was JPT Peptides Technologies (BioNTech) founded?
JPT Peptides Technologies (BioNTech) was founded in 2004.
-
Where is JPT Peptides Technologies (BioNTech) headquartered?
JPT Peptides Technologies (BioNTech) is headquartered in Berlin, Germany.
-
What is the size of JPT Peptides Technologies (BioNTech)?
JPT Peptides Technologies (BioNTech) has 61 total employees.
-
What industry is JPT Peptides Technologies (BioNTech) in?
JPT Peptides Technologies (BioNTech)’s primary industry is Drug Discovery.
-
Is JPT Peptides Technologies (BioNTech) a private or public company?
JPT Peptides Technologies (BioNTech) is a Private company.
-
What is JPT Peptides Technologies (BioNTech)’s current revenue?
The current revenue for JPT Peptides Technologies (BioNTech) is .
-
How much funding has JPT Peptides Technologies (BioNTech) raised over time?
JPT Peptides Technologies (BioNTech) has raised $9.5M.
-
Who are JPT Peptides Technologies (BioNTech)’s investors?
Jerini has invested in JPT Peptides Technologies (BioNTech).
-
Who are JPT Peptides Technologies (BioNTech)’s competitors?
GenScript, Numaferm, ProSci (Poway), ARVYS Proteins, and Eurofins Genomics Americas are some of the 13 competitors of JPT Peptides Technologies (BioNTech).
-
When was JPT Peptides Technologies (BioNTech) acquired?
JPT Peptides Technologies (BioNTech) was acquired on 31-Mar-2021.
-
Who acquired JPT Peptides Technologies (BioNTech)?
JPT Peptides Technologies (BioNTech) was acquired by TheraCode.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
